Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3169647 | Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology | 2007 | 15 Pages |
Abstract
These evidence-based management recommendations should guide the clinician's management decisions for patients with salivary dysfunction related to systemic disease. Future treatment strategies may include new formulations of existing drugs, e.g., local application of pilocarpine. Recent discoveries on gene expression and a better understanding of the etiopathogenesis of SS may open new treatment options in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Inger DDS, PhD, Thomas P. DMD, Philip C. DDS, Troy DDS, MS, Roland DMD, PhD, Peter B. DDS, David MD, BDS, Michael T. DDS, MHS, Marco MD, DDS, Beatrice DDS, MSD, Takashi DDS, PhD, Mahvash DMD, Nelson L. DMD, MPH, Morten DDS, Dr Odont,